Attention-Deficit/Hyperactivity Disorder (ADHD) is a condition that often sparks passionate discussion — not only among clinicians, but in wider society. Over the years, many voices have shaped how we think about ADHD. One of the most well-known is Dr Gabor Maté, a physician and bestselling author, whose views sometimes contrast with the broader scientific literature. So, what exactly are these differences — and why do they matter?
Gabor Maté’s Perspective on ADHD
Dr Gabor Maté sees ADHD primarily through the lens of developmental trauma and emotional experience. In his influential book Scattered Minds (1999), Maté argues that ADHD is not merely a genetically inherited brain disorder but is largely shaped by early environmental factors, particularly emotional stress in infancy and childhood.
According to Maté:
ADHD arises from early disruptions in attachment — when a child’s emotional needs are not adequately met, even in subtle ways, the developing brain adapts by tuning out as a defence mechanism.
Neurological differences seen in ADHD are, in his view, the result of these early adaptations, not purely genetic inheritance.
Healing is possible through emotional connection, relational repair, and nurturing environments — not simply through medication.
Maté's approach resonates strongly with many people who feel unseen or misunderstood by traditional medical models. His emphasis on compassion, trauma-awareness, and the importance of understanding the whole person has had a profound impact on how we talk about ADHD.
The Broader Scientific Literature on ADHD
Mainstream research into ADHD paints a somewhat different picture. The majority of the scientific community views ADHD as a neurodevelopmental disorder with a strong biological and genetic basis. According to extensive peer-reviewed studies:
Genetics play a major role: Twin studies consistently show high heritability rates for ADHD, estimated at about 70–80%.
Brain imaging research reveals structural and functional differences in brain regions associated with executive functioning, attention regulation, and impulse control — particularly in the prefrontal cortex and basal ganglia.
Environmental factors (such as prenatal exposure to toxins, early adversity, and parenting styles) can influence the severity or expression of symptoms, but they are not typically seen as primary causes.
Pharmacological treatments (especially stimulant medications like methylphenidate and amphetamines) are well-supported by evidence for their effectiveness in reducing core symptoms of ADHD in children, adolescents, and adults.
Importantly, the scientific view of ADHD has evolved. Today, most clinicians acknowledge that ADHD is complex and multifactorial, involving an interplay of biology, environment, and personal history — but genetics and neurobiology remain central to its classification.
Points of Overlap — and Divergence
Where Gabor Maté and mainstream research agree:
Early environments and relational experiences matter. Childhood trauma, stress, and attachment disruptions can worsen ADHD symptoms and affect long-term outcomes.
ADHD is not a simple matter of “bad behaviour” or “poor self-discipline.”
Healing environments, emotional attunement, and supportive relationships play a crucial role in helping people with ADHD thrive.
Where they diverge:
Maté sees ADHD more as an adaptive response to emotional wounding, whereas mainstream science views ADHD as an intrinsic neurodevelopmental difference, typically present from birth.
Maté places less emphasis on medication, while the literature consistently finds medication to be a frontline treatment option, especially when combined with psychological interventions.
Why This Distinction Matters
Understanding these different perspectives is important for a few reasons:
It affects how we approach treatment: If ADHD is viewed primarily as trauma-based, therapy and emotional healing might be prioritised. If it’s understood as primarily neurological, evidence-based interventions like medication and structured behavioural support may be front and centre.
It influences stigma: Recognising ADHD as a legitimate neurodevelopmental condition helps reduce blame and shame. However, acknowledging the role of early experiences can foster compassion without suggesting that parents are to blame.
It reminds us to stay open: ADHD is not a “one size fits all” experience. Some people might find Maté’s trauma-informed view deeply validating, while others may resonate more with neurodiversity frameworks that celebrate brain differences without framing them through trauma.
Gabor Maté has done something remarkable. He has opened up the conversation about ADHD beyond labels and checklists, inviting us to think more deeply about the human experiences behind the symptoms. At the same time, the robust scientific research on ADHD helps ensure that we approach diagnosis and treatment with precision, responsibility, and care.
Perhaps the most helpful stance is a both/and approach, honouring the biological realities of ADHD and recognising the profound impact of our emotional environments. After all, when it comes to understanding the human mind — very little is ever black and white.
If you or a loved one need support with ADHD please give our team a call on (03) 9882-8874.
To subscribe and listen to our podcast “Breaking the Rules: A Clinician’s Guide to Treating OCD”, click on the following links: Spotify, Google Podcasts, and Apple Podcasts. Episodes will be released fortnightly and will simultaneously be published on our webpage here.